|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01612 VINCENT MED
Nominal 
0.405 0.000 (0.000%) | 2023/12 - Final HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | 124,975 | 75,763 | 119,051 | 208,083 | 31,215 |
| Net Cash from / (used in) Investing Activities | (62,366) | (18,099) | (20,520) | (65,943) | (33,794) |
| Net Cash from / (used in) Financing Activities | (45,367) | (67,836) | (100,951) | (59,489) | (5,409) |
| Increase / (Decrease) in Cash & Cash Equivalents | 17,242 | (10,172) | (2,420) | 82,651 | (7,988) |
| Cash & Cash Equivalents at beginning of period | 159,341 | 173,167 | 169,068 | 69,951 | 81,141 |
| Effect of Foreign Exchange Rate Changes | (799) | (3,654) | 6,519 | 16,466 | (3,202) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 175,784 | 159,341 | 173,167 | 169,068 | 69,951 |
| Remarks: | Real time quote last updated: 13/11/2024 17:47 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 33,288,000 |
| %Change | 25.143% |
| EPS / (LPS) | HKD 0.052 |
| NBV Per Share ($) | HKD 0.864 |